Daniel P. O'Connell is Director at LogicBio Therapeutics, Inc. (LOGC). They have made 1 open-market trade across 1 company since 2018, most recently 2020-12-10.
CIK 0001752965
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $7.0M since 2018, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LOGC | 2,513 | $18K |
Shares reported on the most recent Form 4, priced at the 2020-12-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LOGC | BUY | 2018-10-23 | 2018-10-25 | $10.00 | $7.0M | -13.8% | -11.9% | -11.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.